Scripps Research Institute and IAVI launch world's first dedicated HIV neutralizing antibody center
LA JOLLA, CA, and NEW YORK, NY, September 30, 2008 The Scripps Research Institute, one of the world's largest independent, non-profit biomedical research organizations, and the International AIDS Vaccine Initiative (IAVI), the world's only global non-profit organization focused solely on AIDS vac...
Leading Vaccine Expert Joins IAVI
NEW YORK, July 3 /PRNewswire-USNewswire/ -- Dr. Thomas Hassell, former
global vice president of process development at sanofi pasteur, a leading
vaccine company, has joined IAVI
as vice president for vaccine development.
In his new role, Dr. Hassell will lead IAVI's product development efforts...
DBT And IAVI Forge Partnership To Develop Next Generation Vaccine Candidates
The Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India and the International AIDS Vaccine Initiative signed an agreement today to address a major obstacle in AIDS vaccine development: the design of candidate vaccines to elicit neutralizing antibodies against H...
DBT And IAVI Forge Partnership To Develop “Next Generation” Vaccine Candidats
The Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India and the International AIDS Vaccine Initiative signed// an agreement today to address a major obstacle in AIDS vaccine development: the design of candidate vaccines to elicit neutralizing antibodies against ...
Keystone Symposia to Mark 25th Anniversary of its First HIV/AIDS Meeting
... for scientists, postdoctoral scholars and students from countries where the disease is especially prevalent to travel to the conference. In addition, iavi
(International AIDS Vaccine Initiative) funded four awards. The winners come from 46 countries, and, for many, it will be their first visit to the US....
Hopes for AIDS Vaccine Still Alive Despite Setbacks
...e that a vaccine is do-able, or I wouldn't be working on it," he said.
Find out more about the search for an AIDS vaccine at iavi
SOURCES: Wayne Koff, Ph.D., senior vice president, research and development, International AIDS Vaccine Initiative, New York...
India continues to progress in AIDS vaccine development efforts
... the results will help determine whether and how to move forward with additional testing of this MVA-based AIDS vaccine candidate.
has undertaken work to modify the MVA-based vaccine candidate so that it is ready for large-scale manufacturing should the trial results suggest furth...
World AIDS Vaccine Day 2008
...the development of
safe, effective, accessible, preventive HIV vaccines for use throughout the
world. Founded in 1996 and operational in 24 countries, iavi
network of collaborators research and develop vaccine candidates. IAVI's
financial and in-kind supporters include the Alfred P. Sloan Foundati...
Leading HIV researchers to collaborate on vaccine development
...sponse at the site of initial infection. CHAVI and iavi
hope that by sharing samples, reagents, databases ...s and immunological laboratories around the world, iavi
and its partners have developed a number of tests ...V infection, I am pleased to be collaborating with iavi
and CHAVI. It is critical to investigate the infl...
IAVI and VaxDesign partner to develop a clinical trial in a test tube for AIDS vaccines
...n thousands of these immune simulations per month. iavi
will first test the technology on licensed vaccine... the vaccine. If the technology proves successful, iavi
and VaxDesign will further develop and apply it to...r MIMIC technology. We are excited to partner with iavi
to help develop the next generation of AIDS vaccin...
30+ AIDS vaccine clinical trials in 24 countries, research occurring on every continent
...he next few years," said CEO and President of IAVI, Dr. Seth Berkley.
and its collaborators are currently conducting four ongoing trials in India, Kenya, Rwanda, Uganda, South Africa and the United States. In 2006, iavi
launched a Phase II trial in Uganda and Zambia, part of a multi-site study ...
Research advances quest for HIV-1 vaccine
...nowledge into the design of vaccines capable of stimulating broadly neutralizing antibodies against globally diverse HIV. According to Dr. Wayne Koff, iavi
Sr. VP for Vaccine Research, "Elucidation of the critical features of 4E10 recognition of HIV-1 helps to define potential immunogens able to elicit 4E...